10 results on '"Van Laer, M"'
Search Results
2. Streptococcal toxic shock syndrome in a returning traveller.
- Author
-
Note S, Soentjens P, Van Laer M, Meert P, and Vanbrabant P
- Subjects
- Anti-Bacterial Agents classification, Communicable Diseases, Imported diagnosis, Communicable Diseases, Imported etiology, Diagnosis, Differential, Female, Humans, Middle Aged, Patient Care Management methods, Purpura Fulminans diagnosis, Purpura Fulminans therapy, Surgical Procedures, Operative methods, Travel-Related Illness, Treatment Outcome, Anti-Bacterial Agents administration & dosage, Fasciitis, Necrotizing complications, Fasciitis, Necrotizing diagnosis, Fasciitis, Necrotizing therapy, Fluid Therapy methods, Shock, Septic diagnosis, Shock, Septic etiology, Shock, Septic therapy, Streptococcal Infections diagnosis, Streptococcal Infections physiopathology, Streptococcal Infections therapy, Streptococcus pyogenes isolation & purification
- Abstract
Background: A patient presenting with fever and purpura after a stay in the tropics tempts a physician to make a differential diagnosis mainly focusing on imported diseases. Although the importance of considering a tropical disease is obvious, the fact that cosmopolitan infections account for one third of the cases in a febrile returning traveler must not be overseen. Toxic Shock Syndrome is amongst the most notorious diseases due to the high mortality when inappropriately managed and the association with necrotizing fasciitis. Methods : We present a 60-year old female with fever, shock syndrome and progressive appearance of painful purpura on the lower legs after a 2-week holiday in Zanzibar. Results : The patient was diagnosed with Streptococcal Toxic Shock Syndrome. Treatment focusing on aggressive fluid resuscitation, prompt administration of antibiotics (ceftriaxon, doxycycline and one dose of amikacin) and adjunctive treatment by clindamycin and immunoglobulin was initiated. She was also immediately taken into surgery for a bilateral fasciotomy and surgical exploration of the lower legs. Histology appeared compatible with purpura fulminans, thereby excluding necrotizing fasciitis. No source of infection could be identified. Conclusion : Toxic Shock Syndrome remains a challenging diagnosis and even more in a returning traveler with an extensive differential diagnosis containing both tropical and cosmopolitan diseases. Cornerstones for the treatment of Streptococcal Toxic Shock Syndrome are abrupt administration of antimicrobial therapy comprising beta-lactam antibiotics and clindamycin and surgical exploration to apply source control when indicated.
- Published
- 2019
- Full Text
- View/download PDF
3. Compartment syndrome of the forearm with life-threatening bleeding after fasciotomy as the presenting sign of postpartum acquired hemophilia A: a case report.
- Author
-
Van Laer M, Penaloza A, Stockman W, Meert P, Lambert C, and Hermans C
- Subjects
- Adult, Compartment Syndromes surgery, Female, Forearm pathology, Forearm physiopathology, Hemophilia A diagnosis, Humans, Pregnancy, Pregnancy Complications, Compartment Syndromes etiology, Fasciotomy adverse effects, Hemophilia A complications, Hemorrhage etiology, Postpartum Period
- Abstract
: Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the development of autoantibodies against clotting factor VIII. Although the cause of this disorder remains obscure, it is often linked to malignancies, drug administration, autoimmune diseases and pregnancy. In pregnancy-associated AHA, hemorrhagic symptoms usually present 1-4 months peripartum, however they may occur up to 1-year postpartum. Compartment syndrome of the forearm is also very uncommon complication of AHA but can have devastating consequences. We report a rare case of a compartment syndrome of the forearm in a 30-year-old woman 2.5 months postpartum as the presentation of pregnancy-associated AHA.
- Published
- 2019
- Full Text
- View/download PDF
4. Drug-Drug Interaction of Ergotamine with a Combination of Darunavir, Abacavir, and Lamivudine Causing a Fatal Vasospastic Ischemia.
- Author
-
Petit E, Schoonheydt K, Meert P, and Van Laer M
- Abstract
Ergotamine toxicity has become a rare condition which can be caused by, among others, drug-drug interaction. In this work we report a case with vasospastic ischemia induced by the wrongful combination of ergotamine with recently started Antiretroviral Therapy. Clinicians were not aware that patient was self-medicating for years with medication containing ergotamine and caffeine for migraines. This diagnosis was established after evaluating the evolving 'and spreading' ischemia and CT scans and thoroughly interviewing patient's family. Treatment was started with intravenous nimodipine and intra-arterial sodium nitroprusside on the affected limbs. The patient developed severe limb ischemia, cerebral ischemia, and metabolic encephalopathy. Unfortunately no improvements were noticeable and due to evolving cerebral edema as a result of the ischemia, the patient developed brain herniation and died shortly after.
- Published
- 2018
- Full Text
- View/download PDF
5. Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department.
- Author
-
Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, Occelli C, Feral-Pierssens AL, Truchot J, Ortega M, Carneiro B, Pernet J, Claret PG, Dami F, Bloom B, Riou B, and Beaune S
- Subjects
- Aged, Aged, 80 and over, Area Under Curve, Belgium, Female, France, Humans, Infections mortality, Male, Middle Aged, Normal Distribution, Prognosis, Prospective Studies, ROC Curve, Respiratory Tract Infections mortality, Sex Distribution, Spain, Switzerland, Emergency Service, Hospital statistics & numerical data, Hospital Mortality, Organ Dysfunction Scores, Sepsis mortality
- Abstract
Importance: An international task force recently redefined the concept of sepsis. This task force recommended the use of the quick Sequential Organ Failure Assessment (qSOFA) score instead of systemic inflammatory response syndrome (SIRS) criteria to identify patients at high risk of mortality. However, these new criteria have not been prospectively validated in some settings, and their added value in the emergency department remains unknown., Objective: To prospectively validate qSOFA as a mortality predictor and compare the performances of the new sepsis criteria to the previous ones., Design, Settings, and Participants: International prospective cohort study, conducted in France, Spain, Belgium, and Switzerland between May and June 2016. In the 30 participating emergency departments, for a 4-week period, consecutive patients who visited the emergency departments with suspected infection were included. All variables from previous and new definitions of sepsis were collected. Patients were followed up until hospital discharge or death., Exposures: Measurement of qSOFA, SOFA, and SIRS., Main Outcomes and Measures: In-hospital mortality., Results: Of 1088 patients screened, 879 were included in the analysis. Median age was 67 years (interquartile range, 47-81 years), 414 (47%) were women, and 379 (43%) had respiratory tract infection. Overall in-hospital mortality was 8%: 3% for patients with a qSOFA score lower than 2 vs 24% for those with qSOFA score of 2 or higher (absolute difference, 21%; 95% CI, 15%-26%). The qSOFA performed better than both SIRS and severe sepsis in predicting in-hospital mortality, with an area under the receiver operating curve (AUROC) of 0.80 (95% CI, 0.74-0.85) vs 0.65 (95% CI, 0.59-0.70) for both SIRS and severe sepsis (P < .001; incremental AUROC, 0.15; 95% CI, 0.09-0.22). The hazard ratio of qSOFA score for death was 6.2 (95% CI, 3.8-10.3) vs 3.5 (95% CI, 2.2-5.5) for severe sepsis., Conclusions and Relevance: Among patients presenting to the emergency department with suspected infection, the use of qSOFA resulted in greater prognostic accuracy for in-hospital mortality than did either SIRS or severe sepsis. These findings provide support for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria in the emergency department setting., Trial Registration: clinicaltrials.gov Identifier: NCT02738164.
- Published
- 2017
- Full Text
- View/download PDF
6. Large-scale synthesis and in situ functionalization of Zn3P2 and Zn4Sb3 nanowire powders.
- Author
-
Brockway L, Van Laer M, Kang Y, and Vaddiraju S
- Abstract
A simple method for the large-scale synthesis of gram quantities of compound semiconductor nanowires without the need for any external catalysts or templates is presented. This method is demonstrated using zinc phosphide (Zn3P2) and zinc antimonide (β-Zn4Sb3) nanowires as example systems. Large-scale synthesis of Zn3P2 and Zn4Sb3 nanowire powders was accomplished using a hot-walled chemical vapor deposition chamber by transporting phosphorus and antimony, respectively, via the vapor phase onto heated zinc foils. The zinc foils were rolled concentrically into coils to maximize the substrate surface area, and consequently, the nanowire yield. Using this method, 250 mg of Zn3P2 nanowires were obtained on 480 cm(2) of zinc foil in a span of 45 minutes. Furthermore, a process of exposing the synthesized nanowires to a vapor of organic functional molecules immediately after their synthesis and before their removal from the vacuum chamber was developed to obtain large quantities of surface functionalized nanowire powders. This in situ vapor-phase functionalization procedure passivated the nanowire surfaces without adversely affecting their morphology or dimensions. Our studies revealed that both 4-aminothiophenol and 3-propanedithiol functionalized Zn3P2 nanowires were stable over a 120 day duration without any agglomeration or degradation. This method of mass producing nanowires can also be extended to other binary semiconductors.
- Published
- 2013
- Full Text
- View/download PDF
7. Indications and limits of meniscal allografts.
- Author
-
Verdonk R, Volpi P, Verdonk P, Van der Bracht H, Van Laer M, Almqvist KF, Vander Eecken S, Prospero E, and Quaglia A
- Subjects
- Adult, Female, Follow-Up Studies, Graft Survival, Humans, Joint Instability pathology, Joint Instability physiopathology, Knee Joint pathology, Knee Joint physiopathology, Male, Menisci, Tibial pathology, Menisci, Tibial physiopathology, Patient Satisfaction, Patient Selection, Range of Motion, Articular, Recovery of Function, Retrospective Studies, Second-Look Surgery, Transplantation, Homologous, Treatment Outcome, Joint Instability surgery, Knee Joint surgery, Menisci, Tibial transplantation
- Abstract
Meniscal allograft transplantation has emerged as a useful treatment for carefully selected patients. The aim of this review of meniscal allograft transplantation is to put this procedure into a clinical perspective. Since there still is a lack of consensus on how the success of meniscal transplantation should be evaluated it is difficult to compare study outcomes. Nevertheless, almost all studies report an increase in patient satisfaction and improvement in pain and function. Clinical and functional outcome is improved in the majority of patients. Progression of cartilage degeneration according to MRI and radiological criteria was halted in a number of patients, indicating a chondroprotective effect. Joint space narrowing is only significantly progressive at long-term follow-up. On magnetic resonance imaging, shrinkage is seen after some years, but more in lyophilized allografts. Second-look arthroscopy usually shows good healing to the capsule. Overall, the clinical results of this type of surgery are encouraging and long-lasting in a well selected patient population who suffered a total meniscectomy. Meniscal allografting appears to becoming the golden standard therapy for these type of patients., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
8. Ilizarov treatment for femoral mal-union or non-union associated with fatigue fracture of an intramedullary nail.
- Author
-
Lammens J, Van Laer M, and Motmans R
- Subjects
- Adolescent, Adult, Bone Nails, Diaphyses, Female, Femoral Fractures physiopathology, Fractures, Malunited diagnostic imaging, Fractures, Ununited diagnostic imaging, Fractures, Ununited etiology, Humans, Male, Middle Aged, Radiography, Femoral Fractures surgery, Fracture Fixation, Intramedullary adverse effects, Fractures, Malunited surgery, Fractures, Ununited surgery, Ilizarov Technique, Prosthesis Failure
- Published
- 2008
- Full Text
- View/download PDF
9. Escape of HIV-1 is associated with lack of V3 domain-specific antibodies in vivo.
- Author
-
Schreiber M, Müller H, Wachsmuth C, Laue T, Hufert FT, Van Laer MD, and Schmitz H
- Subjects
- Amino Acid Sequence, Humans, Male, Molecular Sequence Data, Neutralization Tests, Protein Structure, Tertiary, Antibody Specificity, HIV Antibodies analysis, HIV Envelope Protein gp120 immunology, HIV-1 immunology, Peptide Fragments immunology
- Abstract
This study was performed to analyse correlates of viral escape in AIDS patients. Peripheral blood mononuclear cells (PBMC) from HIV- donors were inoculated with AIDS patients' serum to detect neutralization-resistant cell-free virus. Infectious virus was detected by polymerase chain reaction (PCR) and analysed by sequencing the V3 region. The escaped virus species was compared with all V3 virus variants found in the patients' PBMC and plasma. In one patient escaped virus was also compared with variants found in CD4+ T cells isolated by FACS from blood, spleen and lymph node. The frequency of the virus variants was determined by cloning and sequence analysis of 20 V3 clones for each PCR amplification. To monitor anti-V3 antibodies by ELISA, each V3 sequence was expressed as fusion with glutathione S-transferase (GST-V3). In our AIDS patients, a V3-directed antibody response against the infectious virus V3 loop was not detectable. In contrast, virus variants unable to infect the donor PBMC in vitro were well recognized by homologous V3-directed antibody. After an interval of 1 year the frequency of these variants clearly decreased, while at the same time the escaped variants grew out and finally represented the predominant viral species both in plasma and PBMC. The infectious variants lacking V3 antibody response were also predominant in CD4+ T cells in spleen and lymph node. Our data indicate that the escape of virus variants is closely related to the lack of V3-directed antibody.
- Published
- 1997
- Full Text
- View/download PDF
10. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
- Author
-
Zubler RH, Erard F, Lees RK, Van Laer M, Mingari C, Moretta L, and MacDonald HR
- Subjects
- Animals, Antibodies, Anti-Idiotypic physiology, Cell Line, Concanavalin A physiology, Hemolytic Plaque Technique, Humans, Interleukin-2 physiology, Kinetics, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mutation, Thymoma genetics, Thymus Neoplasms genetics, B-Lymphocytes cytology, Lymphocyte Activation, Lymphocyte Cooperation, Lymphokines, T-Lymphocytes immunology, Thymoma immunology, Thymus Neoplasms immunology
- Abstract
In this report we show that three mutagenized sublines of (murine) EL-4 thymoma cells can constitutively activate human and/or murine B cells via an MHC-nonrestricted cell-cell interaction. The activation signal is not by itself mitogenic but renders B cells capable of proliferating in response to interleukin 2 (IL 2). In addition, one of the mutant EL-4 sublines can constitutively respond by release of IL 2 in the presence of IL 1-containing macrophage (P388D1) supernatant. The exact relationships between these functional properties of the mutant EL-4 thymoma cells and those associated with activated normal T helper-cells remain to be established. However, the EL-4 cells provide a unique system to study in parallel murine and human B cell responses. In particular, the following observations were made during the present study. First, anti-Ig antibodies (anti-Ig) were required for B cell activation in conjunction with two EL-4 sublines acting only on murine B cells, whereas with a third subline acting on both murine and human B cells, anti-Ig was not required. Anti-Ig by itself did not lead to significant B cell activation in the absence of mutant EL-4 (or normal T) cells. Second, the growth factor-stimulated proliferation of EL-4-activated B cells, following separation of the B cells from the EL-4 cells, lasted only 2 days. These results, thus, indicate that the requirement for a surface Ig-mediated B cell activation signal depends on the quality/intensity of a direct T cell signal and that cell-cell interactions may exert a more stringent control over the growth factor responsiveness of B cells as compared with T cells.
- Published
- 1985
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.